Emerging and reemerging microbial threats: Nosocomial fungal infections

Archives of Surgery

Volumn 131, Issue 3, 1996, Pages 330-337

  Henderson, Vernon J ^a,b   Hirvela, Elsa R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPERGILLUS; CANDIDA; CLINICAL FEATURE; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; MYCOSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TORULOPSIS; VIRULENCE;

EID: 0029961986     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430150108020     Document Type: Article

References (57)

1. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality [see comments]. Clin Infect Dis 1992;15:414-421.
2. Ellis CA, Spivack ML. The significance of candidemia. Ann Intern Med. 1967; 67:511-522
3. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990: National Nosocomial Infections Surveillance System. J Infect Dis. 1993;167.1247-1251.
4. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989: National Nosocomial Infections Surveillance System. Am J Med. 1991;91.86S-89S.
5. Jarvis WR. Nosocomial outbreaks: the Centers for Disease Control's Hospital Infections Program experience, 1980-1990: Epidemiology Branch, Hospital Infections Program. Am J Med. 1991,91 101S-106S
6. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med. 1987;147:2117-2120.
7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med. 1989; 149:2349-2353.
8. Sherertz RJ, Gledhill KS, Hampton KD, et al. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. J Pediatr. 1992;120:455-461.
9. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642-2645
10. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis Clin Infect Dis. 1993;16:778-784.
11. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute [see comments]. N Engl J Med. 1994;331:1325-1330.
12. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzell JZ Candida sepsis: pathogenesis and principles of treatments Ann Surg 1974;179:697-711
13. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379-390
14. Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WM. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma. 1993;35:290-295.
15. Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med. 1994;154:2093-2097
16. Bartlett JG. Fungal infections. In Nichols RL, Hyslop NE Jr, Bartlett JG, eds. Decision Making in Surgical Sepsis. St Louis, Mo: Mosby-Year Book, 1991 382-386
17. Odds FC Pathogenesis of Candida infections. J Am Acad Dermatol. 1994,31 S2-S5
18. Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995;63:1993-1998
19. Neely AN, Orloff MM, Holder IA Candida albicans growth studies: a hypothesis for the pathogenesis of Candida infections in burns. J Burn Care Rehabil 1992;13:323-329.
20. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters Clin Infect Dis. 1992,15:197-208
21. Dato VM, Dajani AS Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis 1990; 9:309-314.
22. Eppes S, Troutman J, Gutman J Outcome of treatment of candidemia in children whose central catheters were removed or retained Pediatr Infect Dis 1989;8:99-104.
23. Hostetter MK. Handicaps to host defense, effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990;39:271-275.
24. Samaranayake YH, Samaranayake LP. Candida kruser, biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen J Med Microbiol. 1994;41:295-310
25. Sanford G, Merz W, Wingard J, et al The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis. 1980;142:503-509.
26. Walsh TJ, Merz WG Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis Am J Clin Pathol 1986;85.498-502.
27. Chapman SW, Daniel CR. Cutaneous manifestations of fungal infection. Infect Dis Clin North Am. 1994;8:879-910.
28. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9 1-9.
29. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the 'undrained abscess' of multiple organ failure [see comments]. Ann Surg. 1993; 218:111-119.
30. Alexander JW, Boyce ST, Babcock GF, et al. The process of microbial translocation Ann Surg 1990;212:496-511.
31. Hashimoto T. In-vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium Infect Immun. 1991,59:3555-3561.
32. Dyess DL, Garrison RN, Fry DE Candida sepsis: implications of polymicrobial blood-borne infection. Arch Surg. 1985;120:345-348
33. Edwards JE Jr. Candidemia and Candida catheter-associated sepsis: In: Holmberg K, Meyer RD, eds. Diagnosis and Therapy of Systemic Fungal Infections New York, NY: Raven Press; 1989:39-46.
34. Edwards JE. Editorial response: should all patients with candidemia be treated with antifungal agents? Clin Infect Dis 1992,15.422-423
35. Burchard KW, Minor LB, Slotman GJ, Gann DS Fungal sepsis in surgical patients Arch Surg. 1983;118:217-221
36. Parke DW, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89.789-796.
37. Edwards JE, Montgomerie JZ, Ishida K, Morrison JO, Guze LB Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis 1977;135.294-297.
38. Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine. 1974;53.47-75.
39. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985;7: 646-655.
40. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery. 1980;88:524-530
41. Becker WK, Cioffi WG, McManus AT, et al Fungal burn wound infecton, a 10-year experience. Arch Surg. 1991;126:44-48.
42. Vasquez JA, Sobel JD. Fungal infections in the diabetic. Infect Dis Clin North Am. 1995;9.97-116.
43. Kones RJ, Cutitar M, Burchard KW. Perforated peptic ulcer determinants of morbidity and mortality. Am Surg. 1990;56:280-284.
44. Cornwell EE, Belzberg H, Offne TV, et al. The pattern of fungal infections in critically ill surgical patients. Am Surg. 1995;61.847-850.
45. Repentigny LD. Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis. Clin Infect Dis. 1992;14:S11-S22.
46. De Repentigny LD, Marr LD, Keller JW, et al. Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin Microbiol. 1985,21:972-979.
47. Ormala T, Korppi M, Katila ML, Ojanen T, Perkkio M. Prospective evaluation of Candida antigen and antibody assays for detection of Candida infections in children with malignant disease. Acta Paediatr 1995;84 183-187.
48. Chryssanthou E, Andersson B, Petrini B, Lofdahl S, Tollemar J. Detection of Candida albicans DNA in serum by polymerase chain reaction. Scand J Infect Dis. 1994;26:479-485.
49. Rand KH, Houck H, Wolff M. Detection of candidemia by polymerase chain reaction. Mol Cell Probes. 1994,8:215-221.
50. Karp JE, Merz WG, Churache P. Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia Rev Infect Dis. 1991;13:592-599.
51. EORTC International Antimicrobial Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med. 1989;86:668-672.
52. Hughes WT, Armstrong D, Bodey GP, et al Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990, 161:381-396.
53. Marsh PK, Tally FP, Kellum J, Callow A, Gorbach SL Candida infections in surgical patients. Ann Surg 1983;198:42-47
54. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis. 1993, 16:677-688.
55. Perfect JR, Pickard WW, Hunt DL, Palmer B, Schell WA The use of amphotericin B in nosocomial fungal infection. Rev Infect Dis. 1991,13:474-479.
56. Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle PJ Discovery of fluconazole, a novel antifungal agent. Rev Infect Dis 1990;12:S267-S271.
57. Bodey GP. Azole antifungal agents. Clin Infect Dis. 1992;14:S161-S169.